363 related articles for article (PubMed ID: 24764034)
21. ¹⁸F-FDG PET-CT usefulness in extra-pancreatic involvement in IgG4 related diseases.
Cárdenas-Perilla R; Monturiol-Duran J; Simó-Perdigó M; Barios-Profitós M; Castell-Conesa J
Rev Esp Med Nucl Imagen Mol; 2014; 33(6):366-9. PubMed ID: 24630373
[TBL] [Abstract][Full Text] [Related]
22. (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis.
Lei W; Zeng H; Zeng DX; Zhang B; Zhu YH; Jiang JH; Huang JA
Br J Radiol; 2016; 89(1057):20150695. PubMed ID: 26529231
[TBL] [Abstract][Full Text] [Related]
23. Vascular/perivascular inflammation in IgG4-related disease.
Imai S; Tahara N; Igata S; Tahara A; Bekki M; Sugiyama Y; Maeda-Ogata S; Honda A; Otsuka H; Ushijima T; Okabe Y; Kaida H; Abe T; Tanaka H; Fukumoto Y; Tayama E
J Nucl Cardiol; 2022 Dec; 29(6):2920-2933. PubMed ID: 34704218
[TBL] [Abstract][Full Text] [Related]
24. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
[TBL] [Abstract][Full Text] [Related]
26. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
27. 18F-FDG PET/CT in patients with adult-onset Still's disease.
Dong MJ; Wang CQ; Zhao K; Wang GL; Sun ML; Liu ZF; Xu L
Clin Rheumatol; 2015 Dec; 34(12):2047-56. PubMed ID: 25711875
[TBL] [Abstract][Full Text] [Related]
28. IgG4-Related Renal Lesions Detected by Delayed 18F-FDG PET/CT Scan.
Fu Z; Liu M; Zhang J; Li Z; Li Q
Clin Nucl Med; 2017 Jan; 42(1):66-67. PubMed ID: 27764042
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis.
Matsubayashi H; Furukawa H; Maeda A; Matsunaga K; Kanemoto H; Uesaka K; Fukutomi A; Ono H
Pancreatology; 2009; 9(5):694-9. PubMed ID: 19684434
[TBL] [Abstract][Full Text] [Related]
30. Pretherapy
Cheng MF; Guo YL; Yen RF; Wu YW; Wang HP
Korean J Radiol; 2023 Jun; 24(6):590-598. PubMed ID: 37271212
[TBL] [Abstract][Full Text] [Related]
31.
Tang CYL; Chua WM; Cheng LTJ; Fong W; Zaheer S; Lam WW
Br J Radiol; 2021 Aug; 94(1124):20210105. PubMed ID: 34048289
[TBL] [Abstract][Full Text] [Related]
32. [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience.
Bertagna F; Treglia G; Leccisotti L; Bosio G; Motta F; Giordano A; Giubbini R
Jpn J Radiol; 2012 Jun; 30(5):415-21. PubMed ID: 22421932
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease.
Tsuji S; Iwamoto N; Horai Y; Fujikawa K; Fujita Y; Fukui S; Ideguchi R; Michitsuji T; Nishihata S; Okamoto M; Tsuji Y; Endo Y; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Igawa T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kudo T; Kawakami A
Clin Exp Rheumatol; 2021; 39(6):1338-1344. PubMed ID: 33506750
[TBL] [Abstract][Full Text] [Related]
35. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
36. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
37. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
Sharma P; Jain TK; Singh H; Suman SK; Faizi NA; Kumar R; Bal C; Malhotra A; Kumar R
Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
[TBL] [Abstract][Full Text] [Related]
38. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
39. Characterizing POEMS Syndrome with 18F-FDG PET/CT.
Pan Q; Li J; Li F; Zhou D; Zhu Z
J Nucl Med; 2015 Sep; 56(9):1334-7. PubMed ID: 26182964
[TBL] [Abstract][Full Text] [Related]
40. Utility of
Chen J; Li XL; Huang M
Clin Radiol; 2024 Mar; 79(3):205-212. PubMed ID: 38218705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
